Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
Horizon broadens industry-leading gene editing capabilities through extension of key CRISPR license and grant-funded research
Copper Quest Announces Fully Subscribed Private Placement with Continued Support by Strategic International Investor
LaFleur Minerals Appoints Andrew Elinesky as Chief Executive Officer and Provides Update on Beacon Gold Mill Recommissioning Work and Swanson Bulk Sample Progress
